CFG
AZN icon

Capstone Financial Group’s AstraZeneca AZN Stock Holding History

Capstone Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$54K Hold
500
– – 0.04% 124
2020
Q2 		$53K Buy
+500
New +$51.6K 0.04% 119

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capstone Financial Group's AZN Position: Q3 2020 in Review

Capstone Financial Group held its AstraZeneca (AZN) position steady in Q3 2020 at 500 shares worth $54K. The position accounts for 0.04% of the portfolio, ranked #124.

Capstone Financial Group first reported a position in AZN in Q2 2020 and has held it in 2 quarters since. 723 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

  • Capstone Financial Group held 500 shares of AstraZeneca worth $54K as of Q3 2020.
  • Capstone Financial Group left its AstraZeneca share count unchanged in Q3 2020.
  • AstraZeneca made up 0.04% of Capstone Financial Group's portfolio in Q3 2020, its #124 holding.
  • Capstone Financial Group first reported a position in AstraZeneca in Q2 2020 and has held it in 2 quarters since.
  • 723 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on Capstone Financial Group's 13F filing for Q3 2020, filed 9 Oct 2020.